Cytokinetics
Why Robinhood?
Robinhood gives you the tools you need to put your money in motion. You can buy or sell Cytokinetics and other ETFs, options, and stocks.About CYTK
Cytokinetics, Inc. is a biopharmaceutical company, which is focused on discovering, developing, and commercializing muscle activators and muscle inhibitors as potential treatments for people with debilitating diseases in which muscle performance is compromised and/or declining. The firm is developing small molecule drug candidates specifically engineered to impact muscle function and contractility.
CYTK Key Statistics
Stock Snapshot
The current Cytokinetics(CYTK) stock price is $66.18, with a market capitalization of 8.09B. The stock trades at a price-to-earnings (P/E) ratio of -10.61.
On 2025-11-18, Cytokinetics(CYTK) stock traded between a low of $66.00 and a high of $67.80. Shares are currently priced at $66.18, which is +0.3% above the low and -2.4% below the high.
Cytokinetics(CYTK) shares are trading with a volume of 1.29M, against a daily average of 1.99M.
During the past year, Cytokinetics(CYTK) stock moved between $29.31 at its lowest and $67.98 at its peak.
During the past year, Cytokinetics(CYTK) stock moved between $29.31 at its lowest and $67.98 at its peak.
CYTK News
Cytokinetics (CYTK) announced its support of a three-year initiative led by the American Heart Association, AHA, to address disparities in access to care, diagn...
In November 2025, Cytokinetics announced that new data from the MAPLE-HCM trial showed aficamten provided greater improvements than metoprolol in multiple measu...
Meet Your ETF AI Analyst Discover how TipRanks' ETF AI Analyst can help you make smarter investment decisions AI Analyst can help you make smarter investment...
Analyst ratings
81%
of 21 ratingsMore CYTK News
New insider activity at Cytokinetics ( (CYTK) ) has taken place on November 12, 2025. Meet Your ETF AI Analyst Discover how TipRanks' ETF AI Analyst can help yo...